Stocks › KOD

Kodiak Sciences Inc.

KOD·Nasdaq·United States United States·USD
$97.17
-0.73 (-0.75%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
KOD
Kodiak Sciences Inc. · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
KODS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of KOD by members of U.S. Congress · 2 on record
All congressional trades →
PoliticianStockTypeFiledTraded
Christopher L. JacobsChristopher L. JacobsHouse · R · NY KODKodiak Sciences Inc. · Stock Sale
$1,001 - $15,000
Dec 12, 2022 Nov 8, 2022 Filing ↗
Christopher L. JacobsChristopher L. JacobsHouse · R · NY KODKodiak Sciences Inc. · Stock Purchase
$1,001 - $15,000
Sep 9, 2022 Jul 18, 2022 Filing ↗

Whale Activity

Position changes in KOD reported for 2026-09-30 by 249 institutional filers
Increased: 61New: 47Held: 24Decreased: 75Closed: 32No prior filing: 10
  • Increased61
  • New47
  • Held24
  • Decreased75
  • Closed32
  • No prior filing10
FilerSharesValueChange
BAKER BROS. ADVISORS LP21.9M$2.07Bincreased
BlackRock, Inc.3.8M$361.6Mdecreased
PRICE T ROWE ASSOCIATES INC /MD/2.9M$278.1Mdecreased
STATE STREET CORP2.2M$211.3Mdecreased
GOLDMAN SACHS GROUP INC2.0M$188.7Mdecreased
T. Rowe Price Investment Management, Inc.2.0M$186.9Mincreased
Janus Henderson Group Ltd.1.9M$178.0M—
VANGUARD CAPITAL MANAGEMENT LLC1.8M$168.5Mdecreased
RTW INVESTMENTS, LP1.5M$141.1Mheld
Boxer Capital Management, LLC1.5M$140.1Mheld
TCG Crossover Management, LLC1.4M$137.0Mheld
BRAIDWELL LP1.1M$102.9Mdecreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by KOD insiders, by quarter · Form 4
-5.0M-2.5M02.5M5.0M2025 Q1: 02025 Q12025 Q2: -7232025 Q22025 Q3: 02025 Q32025 Q4: 2.6M2025 Q42026 Q1: 02026 Q12026 Q2: -60.0K2026 Q22026 Q3: 1.9M2026 Q32026 Q4: 217.1K2026 Q4

Recent Insider Transactions

550 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director Purchase +81.7K $98.51 $8.1M Nov 5, 2026 Form 4 ↗
BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director Purchase +4,703 $98.51 $463K Nov 5, 2026 Form 4 ↗
BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director Purchase +8,742 $98.51 $861K Nov 4, 2026 Form 4 ↗
BAKER BROS. ADVISORS LP / 667, L.P. / Baker Bros. Advisors (GP) LLC / Baker Brothers Life Sciences LP / BAKER FELIX / BAKER JULIANDirector · Director Purchase +151.9K $98.51 $15.0M Nov 4, 2026 Form 4 ↗
BORGESON JOHN A.Chief Financial Officer Sale −8,514 $87.67 $746K Oct 21, 2026 Form 4 ↗
BORGESON JOHN A.Chief Financial Officer Sale −7,623 $89.74 $684K Oct 21, 2026 Form 4 ↗
BORGESON JOHN A.Chief Financial Officer Sale −5,101 $90.98 $464K Oct 21, 2026 Form 4 ↗
BORGESON JOHN A.Chief Financial Officer Sale −2,985 $91.76 $274K Oct 21, 2026 Form 4 ↗
BORGESON JOHN A.Chief Financial Officer Sale −2,000 $93.71 $187K Oct 21, 2026 Form 4 ↗
BORGESON JOHN A.Chief Financial Officer Sale −2,000 $92.66 $185K Oct 21, 2026 Form 4 ↗
BORGESON JOHN A.Chief Financial Officer Sale −1,677 $89.20 $150K Oct 21, 2026 Form 4 ↗
BORGESON JOHN A.Chief Financial Officer Sale −100 $94.91 $9K Oct 21, 2026 Form 4 ↗
667, L.P.Director · 10% owner Purchase +1,416 $85.89 $122K Sep 29, 2026 Form 4 ↗
667, L.P.Director · 10% owner Purchase +84 $85.89 $7K Sep 29, 2026 Form 4 ↗
667, L.P.Director · 10% owner Purchase +20.0K $85.40 $1.7M Sep 29, 2026 Form 4 ↗
667, L.P.Director · 10% owner Purchase +1,195 $85.40 $102K Sep 29, 2026 Form 4 ↗
667, L.P.Director · 10% owner Purchase +10.4K $84.24 $874K Sep 29, 2026 Form 4 ↗
667, L.P.Director · 10% owner Purchase +619 $84.24 $52K Sep 29, 2026 Form 4 ↗
667, L.P.Director · 10% owner Purchase +196.6K $89.86 $17.7M Sep 28, 2026 Form 4 ↗
667, L.P.Director · 10% owner Purchase +11.7K $89.86 $1.1M Sep 28, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding KOD · SEC Form N-PORT
FundSharesValue% of fundAs of
State Street(R) SPDR(R) S&P(R) Biotech ETF
SPDR SERIES TRUST
1.5M$58.3M0.54%Jun 30, 2026
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
1.3M$50.2M0.00%Jun 30, 2026
iShares Russell 2000 ETF
iShares Trust
1.0M$39.8M0.05%Jun 30, 2026
T. Rowe Price Health Sciences Fund, Inc.1.0M$39.5M0.33%Jun 30, 2026
Artisan International Small-Mid Fund
Artisan Partners Funds Inc.
596.0K$23.2M0.91%Jun 30, 2026
T. Rowe Price New Horizons Fund, Inc.590.8K$23.0M0.16%Jun 30, 2026
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund
T. ROWE PRICE INTEGRATED EQUITY FUNDS, INC.
498.3K$19.4M0.20%Jun 30, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
475.6K$18.5M0.02%Jun 30, 2026
Fidelity Small Cap Index Fund
Fidelity Salem Street Trust
430.5K$17.9M0.05%Jul 31, 2026
T. Rowe Price Small-Cap Stock Fund, Inc.426.5K$16.6M0.18%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list KOD's shares (CUSIP 50015M109), each fund at its latest report since Apr 22, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Alex SilversteinSCHEDULE 13G/A · passive (13G) · 1.8M shares2.9%
    Nov 16, 2026 · ↗
  • Sirenia Capital Management LPSCHEDULE 13G/A · passive (13G) · 1.8M shares2.9%
    Nov 16, 2026 · ↗
  • T. Rowe Price Associates, Inc.SCHEDULE 13G/A · passive (13G) · 2.9M shares4.7%
    Nov 16, 2026 · ↗
  • Felix J. BakerSCHEDULE 13D/A · activist (13D) · 22.0M shares35.0%
    Sep 30, 2026 · ↗
  • Julian C. BakerSCHEDULE 13D/A · activist (13D) · 22.0M shares35.0%
    Sep 30, 2026 · ↗
  • Baker Bros. Advisors (GP) LLCSCHEDULE 13D/A · activist (13D) · 22.0M shares35.0%
    Sep 30, 2026 · ↗
  • Baker Bros. Advisors LPSCHEDULE 13D/A · activist (13D) · 22.0M shares35.0%
    Sep 30, 2026 · ↗
  • T. Rowe Price Associates, Inc.SCHEDULE 13G · passive (13G) · 3.2M shares5.2%
    Aug 14, 2026 · ↗
  • Alex SilversteinSCHEDULE 13G · passive (13G) · 3.5M shares5.7%
    May 15, 2026 · ↗
  • Sirenia Capital Management LPSCHEDULE 13G · passive (13G) · 3.5M shares5.7%
    May 15, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming Kodiak Sciences Inc. as client

No lobbying filings found naming Kodiak Sciences Inc. as the client.

Government Contracts

Federal awards to Kodiak Sciences Inc. · USAspending

No federal contract awards found for Kodiak Sciences Inc..

U.S. Patents

Recent USPTO applications naming Kodiak Sciences Inc.

No USPTO patent applications found for Kodiak Sciences Inc..

Annual Financials

From KOD's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Operating income-$234.4M-$186.8M-$277.3M-$341.4M-$267.1M
Net income-$230.0M-$176.2M-$260.5M-$333.8M-$267.0M
Diluted EPS-$4.32-$3.35-$4.97-$6.39-$5.16
Operating cash flow-$136.0M-$117.3M-$154.2M-$206.5M-$182.3M
Cash and equivalents$209.9M$168.1M$285.5M$190.4M$731.5M
Total assets$351.5M$335.6M$479.4M$666.6M$904.2M
Total liabilities$194.2M$185.3M$213.6M$230.5M$240.9M
Shareholders' equity$157.4M$150.3M$265.8M$436.2M$663.3M

As Kodiak Sciences Inc. tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Mar 31, 2026 ↗

Stock Splits

Every split and reverse split in the price history

No stock splits in KOD's price history.

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.02, 9.01Results of operationsNov 12, 2026
    EDGAR ↗
  • 8-K · Items 8.01, 9.01Other eventsSep 28, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsAug 13, 2026
    EDGAR ↗
  • 8-K · Items 5.07Shareholder voteJun 4, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsMay 7, 2026
    EDGAR ↗

About Kodiak Sciences Inc.

From SEC EDGAR company records
Industry (SIC 2836)Biological Products, (No Diagnostic Substances)
SectorHealthcare
HeadquartersPALO ALTO, CA
IncorporatedDE
Former namesOligasis, LLC